Tumor necrosis factor α plus interleukin 1β treatment protects granulocytopenic mice fromPseudomonas aeruginosalung infection: Role of an unusual inflammatory response-Reference-Cited by-同舟云学术

Tumor necrosis factor α plus interleukin 1β treatment protects granulocytopenic mice fromPseudomonas aeruginosalung infection: Role of an unusual inflammatory response

Published:1995-01 Issue:1-6 Volume:103 Page:447-459
ISSN:0903-4641
Container-title:APMIS
language:en
Short-container-title:

Author:

Amura CLAUDIA R.,Fontan PATRICIA A.,Sanjuan NORBERTO,Nociari MARCELO M.,Buzzola FERNANDA R.,Sordelli DANIEL O.

Publisher

Wiley

Subject

Microbiology (medical),General Medicine,Immunology and Allergy,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1699-0463.1995.tb01131.x/fullpdf

Reference46 articles.

1. The effect of interleukin-1 β and tumor necrosis factor α treatment on the Pseudomonas aeruginosa lung infection in a granulocytopenic mouse model;Amura;Clin. Immunol. Immunopathol.,1994

2. Endothelial-leukocyte adhesion molecules;Bevilacqua;Annu. Rev. Immunol.,1993

3. Antibacterial resistance induced by recombinant interleukin-1 in myelosuppressed mice: effect of treatment schedule and correlation with colony-stimulating activity in the bloodstream;Campanile;Cell. Immunol.,1990

4. Inflammatory cytokines;Cerami;Clin. Immunol. Immunopathol.,1992

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pseudomonas aeruginosaand the host pulmonary immune response;Expert Review of Respiratory Medicine;2007-08

2. Cellular and Molecular Aspects of Pneumonia;Principles of Molecular Medicine;2006

3. Modulation of the innate immune response during respiratory tract infections;Anaesthesia, Pain, Intensive Care and Emergency Medicine — A.P.I.C.E.;2003

4. Regulatory Role of Alveolar Macrophages and Cytokines in Pulmonary Host Defense;Yearbook of Intensive Care and Emergency Medicine 2002;2002

5. Regulatory Role of Alveolar Macrophages and Cytokines in Pulmonary Host Defense;Intensive Care Medicine;2002